Prevalence of suicide ideation among HIV/AIDS patients in China: A systematic review and meta-analysis

Front Public Health. 2023 Feb 23:11:1082521. doi: 10.3389/fpubh.2023.1082521. eCollection 2023.

Abstract

Objective: A systematic review and meta-analysis was performed to evaluate the prevalence of suicide ideation among HIV/AIDS patients in China.

Methods: Systematic search of CNKI, Wanfang, China biology medicine database, Weipu, EMBASE, Web of science and PubMed for studies related to the suicide ideation of HIV/AIDS patients. The incidence of suicide ideation of HIV / AIDS patients in China was investigated by meta-analysis.

Results: A total of 16 studies were included (n = 6,174). The incidence of suicidal ideation in HIV/AIDS patients was 30.6% (95%CI: 21.4-39.9%). The results of subgroup analysis showed that the incidence of suicidal ideation in male was 36.1%, which was higher than that in female (32.8%), homosexual patients (39.7%) higher than heterosexual patients (27.1%), 2013-2021 survey (35.2%) higher than 2003-2012 survey (26.5%), the unmarried patients (39.6%) were higher than the married patients (34.5%), the patients diagnosed >1 year (28.4%) were higher than the patients diagnosed <1 year (27.6%), and the depression patients (34.3%) were higher than patients without depression (20.5%) and CD4 cell counts ≤200 cells/ul group (20.6%) were higher than those in >400 cells/ul group (19.8%).

Conclusion: The incidence of suicide ideation in HIV/AIDS patients in China is relatively high.

Keywords: HIV/AIDS; acquired immunodeficiency syndrome; meta-analysis; prevalence; suicide ideation.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome*
  • China / epidemiology
  • Female
  • Humans
  • Male
  • Prevalence
  • Sexual and Gender Minorities*
  • Suicidal Ideation

Grants and funding

The work was supported by the National Natural Science Foundation of China (No. 82104244), Wuxi Municipal Health Commission (Nos. Q202050, Q202101, Q202167, M202167, and ZH202110), Wuxi Taihu Talent Project (Nos. WXTTP2020008 and WXTTP2021), Wuxi Medical Development Discipline Project (No. FZXK2021012), Jiangsu Research Hospital Association for Precision Medication (JY202105), Wuxi City Philosophy and Social Science Project (WXSK20-B-28), and Wuxi City Soft Science Project (KX-21-C230).